featured
IgE Blockade With Omalizumab Reduces Pruritus Related to Immune Checkpoint Inhibitors and Anti-HER2 Therapies
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Annals of Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
IgE Blockade With Omalizumab Reduces Pruritus Related to Immune Checkpoint Inhibitors and Anti-HER2 Therapies
Ann. Oncol 2021 Jun 01;32(6)736-745, DM Barrios, GS Phillips, AN Geisler, SR Trelles, A Markova, SJ Noor, EA Quigley, HC Haliasos, AP Moy, AM Schram, J Bromberg, SA Funt, MH Voss, A Drilon, MD Hellmann, EA Comen, S Narala, AB Patel, M Wetzel, JY Jung, DYM Leung, ME LacoutureFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.